Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Positioning Dipeptidyl Peptidase-1 Inhibitors in Bronchiectasis: No Drug Is an Island.
Journal: American journal of respiratory and critical care medicine
Published: October 06, 2025
In patients with bronchiectasis, daily brensocatib reduced annualized pulmonary exacerbation rates.
Journal: Annals of internal medicine
Published: August 04, 2025
A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis.
Journal: Clinical pharmacokinetics
Published: July 10, 2025
Dipeptidyl peptidase 1 inhibitors for inflammatory respiratory diseases: mechanisms, clinical trials, and therapeutic prospects.
Journal: Frontiers in pharmacology
Published: June 29, 2025
A profile of brensocatib for non-cystic fibrosis bronchiectasis.
Journal: Expert review of respiratory medicine
Published: May 19, 2025
Neutrophil dysfunction in bronchiectasis: Pathophysiological insights and emerging targeted therapies.
Journal: Multidisciplinary respiratory medicine
Published: May 03, 2025
Brensocatib in Bronchiectasis - A New Sheriff in Town?
Journal: The New England journal of medicine
Published: April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
Journal: The New England journal of medicine
Published: April 23, 2025
Last Updated: 10/31/2025